1. Home
  2. GFI vs ONC Comparison

GFI vs ONC Comparison

Compare GFI & ONC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Gold Fields Limited

GFI

Gold Fields Limited

HOLD

Current Price

$49.17

Market Cap

36.5B

ML Signal

HOLD

ONC

BeiGene Ltd. American Depositary Shares

HOLD

Current Price

$309.50

Market Cap

31.4B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
GFI
ONC
Founded
1887
2010
Country
South Africa
Switzerland
Employees
6560
12000
Industry
Precious Metals
Biotechnology: Pharmaceutical Preparations
Sector
Basic Materials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
36.5B
31.4B
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
GFI
ONC
Price
$49.17
$309.50
Analyst Decision
Buy
Strong Buy
Analyst Count
7
12
Target Price
$45.57
$374.75
AVG Volume (30 Days)
3.3M
187.3K
Earning Date
03-30-2026
05-06-2026
Dividend Yield
2.90%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$41.36
$747.23
Revenue Next Year
N/A
$15.78
P/E Ratio
$25.02
$614.06
Revenue Growth
N/A
N/A
52 Week Low
$20.90
$227.40
52 Week High
$61.52
$385.22

Technical Indicators

Market Signals
Indicator
GFI
ONC
Relative Strength Index (RSI) 55.50 54.97
Support Level $48.33 $307.93
Resistance Level $53.26 $320.35
Average True Range (ATR) 2.13 7.68
MACD 1.00 4.77
Stochastic Oscillator 72.96 82.89

Price Performance

Historical Comparison
GFI
ONC

About GFI Gold Fields Limited

Gold Fields Ltd is a producer of gold and is a holder of gold reserves and resources in South Africa, Ghana, Australia and Peru. In Peru, the company also produces copper. The company is involved in underground and surface gold and surface copper mining and silver and related activities, including exploration, extraction, processing and smelting. It conducts underground and surface mining operations at St. Ives, underground-only operations at Agnew, Granny Smith and South Deep and surface-only open pit mining at Damang, Tarkwa and Cerro Corona. The company's revenues are derived from the sale of gold that it produces.

About ONC BeiGene Ltd. American Depositary Shares

BeOne Medicines Ltd is a holding company. Through its subsidiaries, it operates as an oncology-focused biopharmaceutical company engaged in the discovery and development of treatments for cancer. Its portfolio includes BRUKINSA (a Bruton's tyrosine kinase (BTK) inhibitor), sonrotoclax (a B-cell lymphoma 2 (BCL2) inhibitor, and a BTK chimeric degradation activation compound (BTK-CDAC). The company develops and commercializes wholly owned therapeutic assets targeting multiple mechanisms of action in oncology. The company operates in one segment: pharmaceutical products. It generates the majority of its revenue from the sale of its biopharmaceutical products.

Share on Social Networks: